Literature DB >> 24876351

Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.

Stéphanie Michineau1, Grégory Franck1, Orianne Wagner-Ballon1, Jianping Dai1, Eric Allaire1, Marianne Gervais1.   

Abstract

OBJECTIVE: Inflammation plays a critical role in the development of abdominal aortic aneurysms (AAAs). Because stromal cell-derived factor 1 (SDF-1) is known for its ability to attract inflammatory cells, we investigated whether SDF-1/chemokine (C-X-C motif) receptor 4 (CXCR4) axis is expressed in aneurysmal aortic wall and plays a role in AAA physiopathology and asked whether its blockade modulates AAA formation and expansion. APPROACH AND
RESULTS: Quantitative real-time polymerase chain reaction analysis showed that SDF-1α and CXCR4 mRNA levels are increased in both human and CaCl2-induced mouse AAA wall and are positively correlated to the aortic diameter in mice. ELISA quantification and immunostaining demonstrated that, in mice, aortic SDF-1α is rapidly induced during AAA formation, first by apoptotic vascular smooth muscle cells in the injured media and then by adventitial macrophages once AAA is fully established. Using green fluorescent protein-positive (GFP(+/-)) bone marrow transplantation experiments, we demonstrated that aortic SDF-1 overexpression is implicated in the recruitment of bone marrow-derived macrophages within the AAA wall. Furthermore, in mice, blockade of CXCR4 by AMD3100 decreases the infiltration of adventitial macrophages, inhibits AAA formation, and prevents aortic wall destruction. AMD3100 reduces the mRNA levels of MMP-12 and MMP-14 as well as that of inflammatory effectors MCP-1, MIP-1β, MIP-2α, RANTES, IL-1β, IL-6, TNF-α, and E-selectin. Finally, AMD3100 stabilizes the diameter of formed, expanding AAAs in 2 experimental models.
CONCLUSIONS: SDF-1/CXCR4 axis is upregulated in human and mouse AAAs. Blockade of CXCR4 with AMD3100 suppresses AAA formation and progression in two rodent models. Blockade of SDF-1/CXCR4 axis may represent a new strategy to limit progression of small human AAAs.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  aortic aneurysm, abdominal; chemokine CXCL12; inflammation; pharmacology

Mesh:

Substances:

Year:  2014        PMID: 24876351     DOI: 10.1161/ATVBAHA.114.303913

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  21 in total

Review 1.  Monocytes and macrophages in abdominal aortic aneurysm.

Authors:  Juliette Raffort; Fabien Lareyre; Marc Clément; Réda Hassen-Khodja; Giulia Chinetti; Ziad Mallat
Journal:  Nat Rev Cardiol       Date:  2017-04-13       Impact factor: 32.419

2.  Chemokine (C-X-C motif) receptor 2 blockade by SB265610 inhibited angiotensin II-induced abdominal aortic aneurysm in Apo E-/- mice.

Authors:  Hao Nie; Hong-Xia Wang; Cui Tian; Hua-Liang Ren; Fang-Da Li; Chao-Yu Wang; Hui-Hua Li; Yue-Hong Zheng
Journal:  Heart Vessels       Date:  2018-12-07       Impact factor: 2.037

3.  Thrombospondin-1 (TSP1) contributes to the development of vascular inflammation by regulating monocytic cell motility in mouse models of abdominal aortic aneurysm.

Authors:  Zhenjie Liu; Stephanie Morgan; Jun Ren; Qiwei Wang; Douglas S Annis; Deane F Mosher; Jing Zhang; Christine M Sorenson; Nader Sheibani; Bo Liu
Journal:  Circ Res       Date:  2015-05-04       Impact factor: 17.367

Review 4.  Abdominal aortic aneurysm: novel mechanisms and therapies.

Authors:  Frank M Davis; Debra L Rateri; Alan Daugherty
Journal:  Curr Opin Cardiol       Date:  2015-11       Impact factor: 2.161

Review 5.  Disturbed flow's impact on cellular changes indicative of vascular aneurysm initiation, expansion, and rupture: A pathological and methodological review.

Authors:  Kevin Sunderland; Jingfeng Jiang; Feng Zhao
Journal:  J Cell Physiol       Date:  2021-09-06       Impact factor: 6.384

6.  Background differences in baseline and stimulated MMP levels influence abdominal aortic aneurysm susceptibility.

Authors:  Matthew A Dale; Melissa K Suh; Shijia Zhao; Trevor Meisinger; Linxia Gu; Vicki J Swier; Devendra K Agrawal; Timothy C Greiner; Jeffrey S Carson; B Timothy Baxter; Wanfen Xiong
Journal:  Atherosclerosis       Date:  2015-10-08       Impact factor: 5.162

Review 7.  Abdominal Aortic Aneurysm: Evolving Controversies and Uncertainties.

Authors:  Davide Carino; Timur P Sarac; Bulat A Ziganshin; John A Elefteriades
Journal:  Int J Angiol       Date:  2018-05-29

8.  Association of SDF1 and MMP12 with Atherosclerosis and Inflammation: Clinical and Experimental Study.

Authors:  María Marcos-Jubilar; Josune Orbe; Carmen Roncal; Florencio J D Machado; José Antonio Rodriguez; Alejandro Fernández-Montero; Inmaculada Colina; Raquel Rodil; Juan C Pastrana; José A Páramo
Journal:  Life (Basel)       Date:  2021-05-01

9.  Predicting Abdominal Aortic Aneurysm Target Genes by Level-2 Protein-Protein Interaction.

Authors:  Kexin Zhang; Tuoyi Li; Yi Fu; Qinghua Cui; Wei Kong
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

10.  Transcriptome sequencing revealed candidate genes relevant to mesenchymal stem cells' role in aortic dissection patients.

Authors:  Junlin Yang; Sili Zou; Mingfang Liao; Lefeng Qu
Journal:  Mol Med Rep       Date:  2017-10-20       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.